• Return to Headlines

Downtrend Call Working As Exelixis Inc Stock Falls 26.9% (EXEL)

By Amy Schwartz

SmarTrend identified a Downtrend for Exelixis Inc (NASDAQ:EXEL) on February 28th, 2018 at $26.69. In approximately 4 months, Exelixis Inc has returned 26.93% as of today's recent price of $19.50.

Exelixis Inc share prices have moved between a 52-week high of $32.50 and a 52-week low of $7.20 and are now trading 171% above that low price at $19.50 per share. In the last five trading sessions, the 50-day moving average (MA) has fallen 0.7% while the 200-day MA has slid 0.5%.

Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of small-molecule therapeutics for the treatment of cancer and other serious diseases. The Company is building a portfolio of compounds it believes could become pharmaceutical products. Exelixis has strategic alliances with pharmaceutical and biotechnology companies.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Exelixis Inc.

Log in and add Exelixis Inc (EXEL) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights exelixis inc

Ticker(s): EXEL